Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.

CONCLUSION: ADA is an effective treatment option for patients with PsA with or without axial involvement. Compared with ADA monotherapy, the use of concomitant MTX with ADA does not improve articular or skin outcomes in patients with PsA regardless of axial symptoms. TRIAL REGISTRATION: Clinicaltrials.gov NCT01111240. PMID: 26669916 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26669916?dopt=Abstract

Source: J Rheumatol - December 15, 2015 Category: Rheumatology Authors: Behrens F, Koehm M, Arndt U, Wittig BM, Greger G, Thaçi D, Scharbatke E, Tony HP, Burkhardt H Tags: J Rheumatol Source Type: research